Major cardiac concerns in therapy and vaccinations for COVID-19.
Metabol Open
; 11: 100102, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1284381
ABSTRACT
The necessity and impact of SARS-CoV-2 on the world's health have led to the development and production of practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. In this review, we discussed the cardiovascular alteration in SARS-CoV-2 treatment, and we also reviewed the vaccination information and studies that have been done to primary considerations for cardiac patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Metabol Open
Year:
2021
Document Type:
Article
Affiliation country:
J.metop.2021.100102
Similar
MEDLINE
...
LILACS
LIS